Why the study?
Venous thromboembolism is the third most common cause of death worldwide with globally differing incidence rates, warranting an examination of diverse risk factors and molecular mechanisms.
Key points are not available for this paper at this time.
Design
Comprehensive review
Answers are grounded in this paper and cite their sources.
May support tailored VTE prophylaxis by cancer type now; leaves open molecular pathways as targets for future studies.
Venous thromboembolism (VTE) is the third most common cause of death worldwide even though incidence rates differ globally. Western nations report 1 to 2 cases per 1,000 person-years, while Eastern countries exhibit lower rates (<1 per 1,000 person-years). This comprehensive review delves into diverse VTE risk factors including gender, diabetes, obesity, smoking, genetic mutations, hormonal influences, travel, infections, trauma, and cancer. Notably, VTE incidence is highest in certain cancers (such as pancreatic, liver, and non-small-cell lung cancers) and lowest in others (such as breast, melanoma, and prostate cancers). The extensive review provides essential information about prevalent factors and explores potential molecular mechanism contributing to VTE.
No takes yet. Share an insight, caveat, or question.
Mahani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: